BioLineRx Ltd. (BLRX)

BioLineRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Cash & Equivalents	4.63	2.5	3.25	7.91	7.19	9.04	10.44	8.84	9.62	5.99	4.26	7.73	10.1	9.07	10.59	13.11	14	11.45	12.99	14.08
Short-Term Investments	8.45	14.85	17.63	17.3	20.97	17.33	9.13	20.34	30.44	22.18	38.74	18.24	22.71	34.22	40.5	44.16	29.15	39.14	44.15	48.13
Cash & Short-Term Investments	13.08	17.35	20.88	25.21	28.16	26.37	19.56	29.17	40.06	28.17	42.99	25.97	32.82	43.29	51.08	57.26	43.15	50.59	57.14	62.21
Cash Growth (YoY)	-53.56%	-34.19%	6.72%	-13.58%	-29.71%	-6.40%	-54.50%	12.34%	22.08%	-34.92%	-15.83%	-54.65%	-23.94%	-14.44%	-10.59%	-7.95%	-34.20%	-12.90%	152.95%	198.68%
Accounts Receivable	-	-	0.05	-	0.08	1.47	2.48	3.61	3.18	2.83	0.36	-	-	-	-	-	-	-	-	-
Other Receivables	0.73	1.89	0.41	0.7	0.2	0.45	1.39	0.35	0.66	0.51	0.35	0.32	0.13	0.3	0.72	0.14	0.24	0.19	0.14	0.19
Receivables	0.73	1.89	0.46	0.7	0.28	1.92	3.86	3.96	3.84	3.34	0.71	0.32	0.13	0.3	0.72	0.14	0.24	0.19	0.14	0.19
Inventory	2.17	2.16	2.15	2.18	2.85	3.32	3.15	3.54	3.63	2.89	1.95	1.35	-	-	-	-	-	-	-	-
Prepaid Expenses	0.38	0.18	0.2	0.43	0.57	0.31	0.44	1.17	1.58	1.29	1.05	1.17	1.75	0.74	0.2	0.54	0.72	0.16	0.13	0.45
Other Current Assets	-	-	-	-	-	-	0.09	-	-	-	0.48	-	-	-	-	-	-	-	-	-
Total Current Assets	16.35	21.58	23.68	28.52	31.86	31.92	27.1	37.85	49.11	35.69	47.18	28.81	34.69	44.33	52	57.94	44.1	50.94	57.4	62.85
Property, Plant & Equipment	0.8	0.87	0.86	0.89	1	1.16	1.35	1.65	1.8	1.72	1.89	2.02	2.23	2.36	2.5	2.02	2.03	2.13	2.28	2.35
Other Intangible Assets	16.33	16.35	16.37	10.39	10.41	10.43	10.45	13.25	13.69	14.19	14.85	22.03	22.01	21.96	21.89	21.72	21.7	21.7	21.7	21.71
Total Assets	33.48	38.8	40.91	39.8	43.27	43.51	38.91	52.74	64.6	51.6	63.93	52.86	58.94	68.65	76.38	81.67	67.84	74.77	81.39	86.91

Liabilities

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Accounts Payable	4.29	4.91	3.49	3.54	3.47	4.69	5.58	4.63	6.27	8.26	10.87	8.44	6.73	7.14	6.97	5.83	7.34	5.78	5.57	5.44
Accrued Expenses	-	-	1.21	2.13	2.77	1.75	3.13	-	-	-	3.27	-	-	-	1.66	-	-	-	1.23	-
Current Portion of Long-Term Debt	4.48	4.48	4.48	4.48	4.48	4.68	4.48	9.82	10.66	3.68	3.15	3.08	3.08	2.56	1.54	0.8	1.01	1.9	2.76	3.58
Current Portion of Leases	0.28	0.25	0.23	0.3	0.41	0.44	0.52	0.52	0.5	0.47	0.53	0.53	0.38	0.38	0.43	0.15	0.15	0.15	0.17	0.17
Current Unearned Revenue	-	-	-	-	-	-	-	2.26	5.48	9.03	12.96	-	-	-	-	-	-	-	-	-
Other Current Liabilities	4.63	3.99	2.71	3.23	4.36	2.46	1.69	7.74	7.62	2.46	12.02	2.68	2.26	1.97	0.08	1.35	1.13	1.26	0	1.13
Total Current Liabilities	13.68	13.62	12.12	13.67	15.48	14.03	15.41	24.96	30.52	23.89	42.78	14.73	12.45	12.04	10.68	8.13	9.63	9.1	9.72	10.31
Long-Term Debt	2.22	3.36	4.46	5.6	6.72	7.63	8.96	17.98	18.79	5.94	6.63	8.46	8.5	8.24	8.63	8.35	-	-	-	-
Long-Term Leases	0.96	0.98	0.98	1	1	0.99	1.08	1.29	1.31	1.23	1.29	1.25	1.59	1.7	1.73	1.51	1.45	1.66	1.73	1.68
Other Long-Term Liabilities	-	-	-	-	-	-	-	-	-	7.49	-	15.29	15.35	7.55	4.51	8.16	0.19	0.6	1.86	4.01
Total Liabilities	16.86	17.96	17.56	20.27	23.2	22.65	25.45	44.24	50.62	38.54	50.7	39.72	37.88	29.53	25.54	26.15	11.27	11.36	13.3	16

Shareholders' Equity

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Common Stock	73.78	73.43	73.43	73.43	71.82	62.57	38.1	34.43	34.41	31.36	31.36	28.33	27.1	27.1	27.1	27.1	21.16	21.07	21.07	20.87
Additional Paid-In Capital	327.93	327.58	327.58	327.26	327.48	333.63	353.69	353.01	352.43	355.48	355.48	345.46	339.05	339.04	338.98	338.84	339.67	339.44	339.35	338.05
Retained Earnings	-405.63	-402.6	-401	-399.62	-398.64	-394.7	-399.83	-396.64	-390.82	-391.3	-390.61	-376.72	-360.7	-342.15	-329.99	-324.26	-317.41	-309.97	-305.04	-300.74
Comprehensive Income & Other	17.7	18.26	18.19	18.47	19.42	19.37	21.5	17.71	17.96	17.53	16.99	16.06	15.61	15.13	14.76	13.85	13.16	12.87	12.72	12.71
Total Common Equity	13.77	16.67	18.2	19.53	20.07	20.86	13.46	8.51	13.98	13.06	13.22	13.13	21.05	39.11	50.84	55.52	56.57	63.41	68.09	70.9
Minority Interest	2.85	4.16	5.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shareholders' Equity	16.62	20.84	23.35	19.53	20.07	20.86	13.46	8.51	13.98	13.06	13.22	13.13	21.05	39.11	50.84	55.52	56.57	63.41	68.09	70.9
Total Liabilities & Equity	33.48	38.8	40.91	39.8	43.27	43.51	38.91	52.74	64.6	51.6	63.93	52.86	58.94	68.65	76.38	81.67	67.84	74.77	81.39	86.91

Additional Metrics

Fiscal Quarter	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021
Total Debt	7.94	9.07	10.15	11.38	12.6	13.74	15.04	29.61	31.26	11.31	11.59	13.31	13.54	12.88	12.32	10.81	2.61	3.71	4.65	5.42
Net Cash (Debt)	5.14	8.28	10.73	13.83	15.56	12.63	4.52	-0.44	8.81	16.86	31.4	12.66	19.28	30.41	38.76	46.45	40.53	46.88	52.48	56.78
Net Cash Growth (YoY)	-66.98%	-34.40%	137.20%	-	76.67%	-25.10%	-85.60%	-	-54.33%	-44.56%	-18.98%	-72.76%	-52.44%	-35.14%	-26.15%	-18.20%	-31.69%	-8.49%	252.17%	354.15%
Net Cash Per Share	0.00	0.00	0.00	0.01	0.01	0.01	0.00	-0.00	0.01	0.02	0.03	0.01	0.02	0.03	0.04	0.06	0.06	0.07	0.07	0.08
Filing Date Shares Outstanding	2,621	2,611	2,611	2,611	2,558	2,233	2,233	1,200	1,199	1,087	1,087	969.92	922.96	922.96	922.96	715.16	718.28	715.16	715.16	709.12
Total Common Shares Outstanding	2,621	2,611	2,611	2,611	2,558	2,233	1,337	1,200	1,199	1,087	1,087	969.92	922.96	922.96	922.96	715.16	718.28	715.16	715.16	709.12
Working Capital	2.67	7.96	11.56	14.86	16.38	17.89	11.7	12.89	18.59	11.81	4.4	14.08	22.25	32.29	41.32	49.81	34.47	41.84	47.69	52.53
Book Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.04	0.06	0.08	0.08	0.09	0.10	0.10
Tangible Book Value	-2.56	0.33	1.83	9.15	9.66	10.43	3.01	-4.74	0.29	-1.13	-1.63	-8.89	-0.96	17.15	28.96	33.81	34.86	41.71	46.38	49.2
Tangible Book Value Per Share	-0.00	0.00	0.00	0.00	0.00	0.00	0.00	-0.00	0.00	-0.00	-0.00	-0.01	-0.00	0.02	0.03	0.05	0.05	0.06	0.06	0.07
Machinery	-	-	2.11	-	-	-	2.29	-	-	-	2.93	-	-	-	2.81	-	-	-	2.66	-
Leasehold Improvements	-	-	2.04	-	-	-	2.04	-	-	-	2.04	-	-	-	2.04	-	-	-	2.03	-

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 21, 2026

Data Sources Report a data error